Education First Clinical Trial Recruitment

PRIMR has a rigorous process for maintaining excellence including in-house review by a board-certified physician, peer and patient advocate reviews, Institutional Review Board (IRB) in the US and independent ethics committee (IEC) review in the EU, as well as content updates based on protocol changes or study guidelines.

PRIMR incorporates a variety of visual elements and formats beyond just images and diagrams. PRIMR considers factors such as the selection of onscreen text and the simplicity of graphics to appeal to different learning styles. Even color is considered to ensure emphasis on important concepts. The writing of PRIMIR content in itself is meant to replicate how a physician would speak to their patient in clinic, which may or may not include visuals during the visit.‍

PRIMR’s approach to ensuring low-risk content approval by IRBs involves rigorous processes and adherence to regulatory standards. With a track record of 100% IRB approval on first submission for our content over 4 years, PRIMR demonstrates its commitment to compliance and quality assurance. PRIMR employs thorough review processes, collaboration with key opinion leaders in our network, and adherence to industry best practices to achieve consistent approval rates. Other content vendors lack oncology expertise, outsource expert review, slowing down the process, increasing costs and lowering the ultimate quality of the product and impact on patient understanding.

PRIMR ensures effective reach and addresses lopsided demographics in clinical trials through strategic geo-targeted ads and multilingual content creation. By tailoring content distribution to specific geographic regions and providing multilingual materials, PRIMR aims to enhance trial awareness among diverse populations, thus promoting better representation in clinical trials.

Yes. PRIMR can be implemented at the enterprise level. We also offer enterprise licensing for access to PRIMR simply for HIPAA secure point of care distribution of home grown digital patient education content.

At this stage we are handling specific content requests case by case. Content requests for for a specific drug, device or institution may be fulfilled for a fee.

Yes. Some physicians create their own content and use PRIMR as a HIPAA secure distribution tool at the point of care.

For clinical trial recruitment, PRIMR tracks patient engagement data including impressions, views, % viewed and geolocation. We report data out to PIs and sponsors monthly. Our analytics show patients watch PRIMR videos 1.9 times on average, suggesting very high level of engagement.